C07C 217/22
By carbon atoms having at least two bonds to oxygen atoms
Official title: by carbon atoms having at least two bonds to oxygen atoms
C07C217/22 (By carbon atoms having at least two bonds to oxygen atoms) appears on 115 US grants and 101 published applications in this corpus.
Search patents in C07C- Granted patents
- 115
- Published applications
- 101
- Assignees
- 84
- Inventors
- 325
- Latest grant
- 21 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 2 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 4 | 0 |
| 1996 | 10 | 0 |
| 1997 | 3 | 0 |
| 1998 | 4 | 0 |
| 1999 | 4 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 3 |
| 2002 | 8 | 5 |
| 2003 | 4 | 3 |
| 2004 | 1 | 13 |
| 2005 | 5 | 7 |
| 2006 | 8 | 7 |
| 2007 | 4 | 8 |
| 2008 | 4 | 10 |
| 2009 | 5 | 1 |
| 2010 | 4 | 2 |
| 2011 | 3 | 3 |
| 2012 | 2 | 3 |
| 2013 | 6 | 4 |
| 2014 | 2 | 2 |
| 2015 | 3 | 4 |
| 2016 | 7 | 3 |
| 2017 | 1 | 4 |
| 2018 | 2 | 3 |
| 2019 | 0 | 0 |
| 2020 | 2 | 4 |
| 2021 | 3 | 1 |
| 2022 | 3 | 3 |
| 2023 | 0 | 2 |
| 2024 | 2 | 3 |
| 2025 | 0 | 3 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- PDIA4 inhibitors and use thereof for inhibiting β-cell pathogenesis and treating diabetes21 Apr 2026US 12,605,353 B2Academia Sinica
- 1,7-diaryl-1,6-heptadiene-3,5-dione derivatives, methods for the production and use thereof26 Mar 2024US 11,938,233 B2UniversitäT Salzburg
- CCL2 inhibitors2 Jan 2024US 11,858,876 B2Lapko Inc
- Functionalized N,N-dialkylamino phenyl ethers and their method of use10 May 2022US 11,325,883 B2Temple University of the Commonwealth System of Higher Education
- Sunscreen formulation25 Jan 2022US 11,229,590 B2
- Anti-tumor compounds and methods of use thereof and synthesis thereof31 Jul 2025US 2025/0241876 A1Atossa Therapeutics, Inc.
- Metabotropic glutamate receptor positive allosteric modulators (pams) and uses thereof5 Jun 2025US 2025/0179000 A1Sanford Burnham Prebys Medical Discovery Institute
- Nucleic acid delivery material15 May 2025US 2025/0152718 A1National University Corporation Tokai National Higher Education and Research System
- Pesticidal and herbicidal compounds and methods of use thereof10 Oct 2024US 2024/0336567 A1AG Plenus Ltd
- Sesquiterpene derivative or pharmaceutically acceptable salt thereof and use thereof13 Jun 2024US 2024/0189268 A1
Most cited
By later US patents
- Selective estrogen receptor modulator79US 7,612,114 B2Eisai R&D Management Co., Ltd. · 2009
- Dicarboxylic acid derivatives with pharmaceutical properties49US 7,674,825 B2Bayer Aktiengesellschaft · 2010
- Fused 7-oxo-pyrimidinyl compounds, preparation, composition and use thereof41US 6,444,816 B1Dr. Reddy's Research Foundation · 2002
- Compounds for the treatment of metabolic disorders40US 6,924,314 B2Wellstat Therapeutics Corporation · 2005
- Compounds for the treatment of metabolic disorders31US 7,012,071 B2Wellstat Therapeutics Corporation · 2006